Incannex Healthcare Limited (IXHL) Stock Forecast
IXHL analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $18.64 average of analyst targets
- Upside to target
- +561.0% from the latest close
- Next earnings
- November 13, 2026 EPS estimate $-0.66
- 52-week range
- $2.56 – $14.37
IXHL analyst ratings
1 analystsNumber of analysts at each rating.
IXHL price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
IXHL earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.52 | −$0.52 | −$0.52 | — | — | 1 |
| Next quarter (Dec '26) | −$0.53 | −$0.53 | −$0.53 | — | — | 1 |
| Current fiscal year (FY2027) | −$2.23 | −$2.23 | −$2.23 | −$2.25 | +0.8% | 1 |
| Next fiscal year (FY2028) | −$2.44 | −$2.44 | −$2.44 | −$2.23 | −9.7% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
IXHL revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 2 |
| Next quarter (Dec '26) | $0 | $0 | $0 | 0.0% | 2 |
| Current fiscal year (FY2027) | $0 | $0 | $0 | 0.0% | 2 |
| Next fiscal year (FY2028) | $0 | $0 | $0 | 0.0% | 2 |
IXHL EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
IXHL EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.51 | −$0.51 | −$0.51 | −$0.51 | −$0.52 | +1.6% | 0 up · 1 down |
| Next quarter (Dec '26) | −$0.59 | −$0.59 | −$0.59 | −$0.59 | −$0.53 | −10.6% | 1 up · 0 down |
| Current fiscal year (FY2027) | −$2.41 | −$2.41 | −$2.41 | −$2.41 | −$2.23 | −7.4% | 1 up · 0 down |
| Next fiscal year (FY2028) | −$2.62 | −$2.62 | −$2.62 | −$2.62 | −$2.44 | −6.7% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
IXHL earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; IXHL beat in 6 of 8.
What analysts expect from IXHL
1 analysts cover Incannex Healthcare; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $18.64, 561.0% above the latest close of $2.82. Analysts expect earnings of −$2.23 per share for FY2027, +0.8% from a year earlier. For FY2028 the average estimate is −$2.44 per share. Incannex Healthcare beat the EPS estimate in 6 of the last 8 quarters.
Related: IXHL income statement, IXHL key metrics, IXHL chart. See the IXHL stock overview for the latest quote and news.
IXHL forecast FAQ
What is Incannex Healthcare's price target?
The average analyst price target for Incannex Healthcare is $18.64, 561.0% above the latest close of $2.82.
Is Incannex Healthcare a buy, hold or sell?
Of 1 analysts covering Incannex Healthcare, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Incannex Healthcare's EPS forecast?
Analysts forecast −$2.23 per share for FY2027 (range −$2.23 to −$2.23); for FY2028 the estimate is −$2.44.
When does Incannex Healthcare report earnings?
Incannex Healthcare is expected to report results for the quarter ending September 30, 2026 on November 13, 2026; the EPS estimate is $-0.66.
Does Incannex Healthcare usually beat earnings estimates?
Incannex Healthcare reported EPS at or above the analyst estimate in 6 of the last 8 quarters.